Small Fiber Neuropathy Treatments

• There is currently no universally accepted cure for small fiber neuropathy, but treating the underlying cause may improve or even reverse symptoms in some patients.
• First-line treatments typically include duloxetine, gabapentin, pregabalin, tricyclic antidepressants, and topical therapies for neuropathic pain. 
• Emerging therapies—including sodium-channel-targeted medications, monoclonal antibodies, and gene-based approaches—are under investigation but are not yet established treatments for most patients.

Small fiber neuropathy (SFN) is a chronic condition characterized by damage to the small nerve fibers responsible for transmitting pain, temperature, and autonomic functions.

Since the disease affects the peripheral nerves, managing its symptoms can be challenging. However, effective small fiber neuropathy treatments are available to help patients live a better life.

Current treatment guidelines generally recommend antidepressants, gabapentinoids, topical therapies, and nonpharmacologic interventions as first-line approaches, while opioids are typically reserved for selected patients with refractory pain.  These approaches aim to reduce pain and manage autonomic symptoms such as dizziness, abnormal sweating, gastrointestinal dysfunction, urinary symptoms, and heart rate abnormalities.

In this guide, we will examine the best treatments for small fiber neuropathy based on the underlying causes and emerging symptoms. We will also explore potential cures for small fiber neuropathy to help you gain a better understanding of this complex condition.

The Approach to Treating Small Fiber Neuropathy

Choosing the right small fiber neuropathy treatments varies depending on the underlying cause. Because treatment effectiveness depends on the underlying cause, an incomplete evaluation may delay symptom improvement and disease management.

The underlying cause of small fiber neuropathy must be treated together with any related neuropathic pain. When a person manages or receives treatment for the underlying medical condition, their neuropathy symptoms may improve or completely disappear.

Addressing the Underlying Causes of Small Fiber Neuropathy

A wide range of conditions, including diabetes, thyroid dysfunction, and HIV, as well as other diseases, can lead to small fiber neuropathy. In some cases, the diagnosis of small fiber neuropathy can also be deemed “idiopathic.”

However, pain is frequently the most troublesome symptom of the condition, regardless of the underlying cause. Therefore, small fiber neuropathy treatment is tailored to managing the pain symptoms as well as identifying and treating the underlying causes.

This requires individuals with diabetes or other metabolic disorders to manage their blood sugar levels, maintain a healthy body weight, and consume a nutritious, balanced diet.

Regular exercise and quitting smoking can aid in the healing of constricted blood vessels that transport vital nutrients to the nerves.

Additional Underlying Causes to Evaluate 

A thorough evaluation for reversible causes of small fiber neuropathy is an important part of treatment planning.

Conditions commonly investigated include:

• Diabetes and prediabetes
• Vitamin B12 deficiency
• Vitamin B6 toxicity
• Copper deficiency
• Thyroid disorders
• Sjögren syndrome
• Sarcoidosis
• Celiac disease
• HIV infection
• Certain medications and toxins

Identifying and correcting these underlying causes may help stabilize neuropathy progression and improve symptoms.

Is There a Cure for Small Fiber Neuropathy?

Although a definitive cure is not currently available for most patients, symptom improvement or reversal may occur when an underlying cause is identified and successfully treated. However, managing the underlying cause can sometimes lead to symptom improvement or even reversal.

Advances in research are ongoing, and new treatments for small fiber neuropathy continue to emerge. In addition, with early diagnosis and personalized treatment plans, patients can alleviate their symptoms and improve their quality of life.

Confirming the Diagnosis

Before initiating treatment, physicians often seek to confirm the diagnosis of small fiber neuropathy and identify potential underlying causes.

Diagnostic testing may include:

• Skin biopsy to measure intraepidermal nerve fiber density
• Quantitative sensory testing (QST)
• Autonomic function testing
• Blood tests for metabolic, nutritional, infectious, and autoimmune disorders

Accurate diagnosis helps guide treatment decisions and improves the likelihood of identifying reversible causes.

Standard Treatments for Small Fiber Neuropathy

Treatment for small fiber neuropathy (SFN) focuses on managing symptoms and addressing the underlying causes. Symptom management focuses on reducing the pain that is associated with small fiber neuropathy.

The key to improving symptoms and preventing the progression of small fiber neuropathy is etiology-specific treatment. Treatment options are selected based on the patient’s:

• Comorbidities: Other health conditions such as diabetes, autoimmune disorders, or vitamin deficiencies can influence treatment choices and impact overall management strategies.
• Concurrent Medications: Medications already being taken for other conditions, such as anticoagulants and certain antidepressants, may interact with small fiber neuropathy treatments and necessitate careful selection of therapies to avoid adverse effects.
• Safety Profile: The risk of side effects or complications associated with treatments will vary for each patient, guiding clinicians to select the most suitable options while minimizing adverse reactions.

Here is an overview of the best treatment options for small fiber neuropathy.

Immunosuppressive Drugs

While there is no cure for small fiber neuropathy, immunosuppressive drugs may be prescribed to help manage the symptoms of SFN. These medications are recommended for patients with autoimmune diseases. They inhibit the immune system and reduce inflammation.

Examples of immunosuppressive treatments for small fiber neuropathy include:

• Azathioprine
• Cyclosporine
• Methotrexate
• Mycophenolate mofetil
• Corticosteroids (e.g., prednisone)

IVIG Therapy

Intravenous immunoglobulin (IVIG) may be considered in selected patients with autoimmune-associated small fiber neuropathy, particularly when conditions such as Sjögren syndrome or sarcoidosis are present.

Evidence supporting IVIG use is mixed. While some observational studies and case series have reported symptom improvement in autoimmune-related SFN, randomized controlled trials have not demonstrated a clear benefit in patients with idiopathic small fiber neuropathy.

Because IVIG is expensive, requires intravenous administration, and may cause side effects such as headaches, thrombosis, and infusion reactions, it is generally reserved for carefully selected patients with evidence of immune-mediated disease.

Additional research is needed to identify which subgroups of patients are most likely to benefit from IVIG treatment.

Opioid or Narcotic-Based Pain Medications

When first-line neuropathic pain treatments fail to provide adequate relief, additional pain-management strategies may be considered. Opioids and narcotic-based medications are potent agents that can help reduce the pain associated with the disease. Examples of these medications include:

• Morphine
• Methadone
• Oxycodone
• Levorphanol
• Hydromorphone

These drugs work by attaching to opioid receptors in the brain and spinal cord to block pain signals and provide relief.

Due to the risks of dependence, tolerance, overdose, and long-term adverse effects, opioids are generally reserved for carefully selected patients with severe refractory pain who have not responded adequately to other therapies.  They are typically reserved as second- or third-line options for intense or breakthrough pain when other treatments are insufficient.

Current neuropathic pain guidelines generally recommend gabapentinoids, antidepressants, and topical therapies before considering opioid medications.

Lidocaine Patches and Creams

Lidocaine patches and topical creams are localized small fiber neuropathy treatments that reduce focal neuropathic pain. These products deliver lidocaine directly to the skin over painful areas.

Lidocaine reduces neuronal membrane permeability to sodium ions, which inhibits nerve conduction and reduces pain signals.

They are often used for specific pain zones, especially when pain is confined to a small area. However, their effectiveness may be limited if pain is widespread or not localized. Skin irritation at the site of application may also occur.

Those who show allergic reactions to the ingredients in these topical therapies might need to consider new treatments for small fiber neuropathy.

Capsaicin Therapy 

Capsaicin-based treatments may provide relief for some patients with localized neuropathic pain. Capsaicin works by reducing the activity of pain-transmitting nerve fibers over time.

High-concentration capsaicin patches (8%) have shown effectiveness in certain neuropathic pain conditions and may be considered for selected patients with focal symptoms. Common side effects include temporary burning, redness, and irritation at the application site.

Capsaicin therapy is generally considered when pain is localized and other topical treatments have provided insufficient relief.

Anti-Seizure Medications

Anti-seizure treatments are prescribed for neuropathic pain in small fiber neuropathy. Medications in this group include:

• Pregabalin (e.g., Lyrica)
• Gabapentin (e.g., Horizant, Gralise)

While these are not cures for small fiber neuropathy, they can modulate nerve activity by affecting voltage-gated calcium channels. This action reduces the abnormal nerve firing that causes burning, shooting, or tingling sensations.

These medications are often first-line treatments due to their proven efficacy and tolerability. Nonetheless, they may cause side effects such as dizziness, fatigue, or weight gain.

Antidepressants

Antidepressants, particularly tricyclic drugs (TCAs) like amitriptyline and serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine, are widely used for neuropathic pain management. Other small fiber neuropathy treatments in this group include:

• Nortriptyline (e.g., Aventyl)
• Desipramine (e.g., Norpramin)
• Venlafaxine (e.g., Effexor)

Antidepressants influence pain perception by modulating neurotransmitters involved in pain pathways.

They are a cornerstone in neuropathic pain treatment. However, they may take several weeks to show benefits and require careful dosing and monitoring for side effects, especially in the elderly or those with cardiac issues.

Management of Autonomic Symptoms 

In addition to pain management, treatment may be necessary for autonomic symptoms caused by small fiber neuropathy.

Depending on the symptoms present, treatment strategies may include:

• Increased fluid and salt intake for orthostatic intolerance
• Compression garments for blood pressure regulation
• Medications to manage gastrointestinal symptoms
• Therapies for bladder dysfunction
• Exercise programs designed to improve cardiovascular conditioning

Because autonomic symptoms vary considerably among patients, treatment plans should be individualized and guided by a healthcare professional.

New Treatments for Small Fiber Neuropathy

New therapies are showing potential for better management of the condition. Here are some of the most promising emerging treatments for small fiber neuropathy.

Novel Pharmacological Agents

• Sodium channel blockers (e.g., lacosamide targeting NaV1.7 mutations): Reduce nerve hyperexcitability by blocking overactive sodium channels.
• Monoclonal antibodies: Target immune components involved in autoimmune-related SFN to modulate inflammation.
• Lacosamide: Has been investigated in some patients with SCN9A (NaV1.7) mutations and may reduce pain in selected cases, although evidence remains limited and it is not currently considered a standard mutation-specific treatment.

Gene Therapy and Molecular Targets

• Sodium channel mutations (SCN9A, SCN10A, SCN11A): Genetic variations that cause abnormal nerve signaling in small fiber neuropathy, with treatments aiming to correct these defects.
• Gene Editing: Researchers are exploring gene-editing technologies as a potential future strategy for correcting disease-causing genetic mutations. However, these approaches remain experimental and are not currently available as standard treatments for small fiber neuropathy.

Receive Care for SFN With AmeriPharma® Specialty

While there is no definitive cure for small fiber neuropathy, many patients find relief through personalized treatment plans. Emerging research continues to explore new treatments for small fiber neuropathy to improve outcomes and reduce complications.

The best treatment for small fiber neuropathy involves a combination of medication, lifestyle modifications, and supportive therapies. If you want to give yourself the best chance at living a full life with this disease, AmeriPharma® Specialty Pharmacy can help.

Our ACHC-accredited specialty pharmacy provides hard-to-find medications and at-home treatments for patients with complex conditions.

Book a call with us today and start receiving small fiber neuropathy treatment with full-service coordination, copay assistance, and 24/7/365 support.